TPP1 and neuronal ceroid lipofuscinosis: Neuronal Ceroid Lipofuscinosis (NCL): NCLs are hereditary metabolic diseases, and only one clinically licensed medication has been proven to be effective in treating CLN2 illness, a particular variant of NCL [67].